%0 Journal Article
%T Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
%A Alberto Anel
%A Amelie Cornillon
%A Bruno Robert
%A Celine Rene
%A Dang-Nghiem Vo
%A Diego Sanchez-Martinez
%A Eva M. Galvez
%A Ewelina Krzywinska
%A Francesco Bertolini
%A Giovanna Talarico
%A Guillaume Cartron
%A Julian Pardo
%A Martin Villalba
%A Nerea Allende-Vega
%A Pierre Martineau
%A Stefania Orecchioni
%A Yosr Hicheri
%A Zhao-Yang Lu
%J Theranostics
%D 2018
%I Ivyspring International Publisher
%R 10.7150/thno.25149
%X Monoclonal antibodies (mAbs) have significantly improved the treatment of certain cancers. However, in general mAbs alone have limited therapeutic activity. One of their main mechanisms of action is to induce antibody-dependent cell-mediated cytotoxicity (ADCC), which is mediated by natural killer (NK) cells. Unfortunately, most cancer patients have severe immune dysfunctions affecting NK activity. This can be circumvented by the injection of allogeneic, expanded NK cells, which is safe. Nevertheless, despite their strong cytolytic potential against different tumors, clinical results have been poor.
%K NK cells
%K monoclonal antibodies (mAbs)
%K antibody-dependent cell cytotoxicity (ADCC)
%K cancer
%U http://www.thno.org/v08p3856.htm